Next Article in Journal
Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients’ Cohort
Next Article in Special Issue
A Review of the Currently Available Antibody Therapy for the Treatment of Coronavirus Disease 2019 (COVID-19)
Previous Article in Journal
Epitope Mapping of Anti-Mouse CCR3 Monoclonal Antibodies Using Flow Cytometry
Previous Article in Special Issue
Neutralizing and Total/IgG Spike Antibody Responses Following Homologous CoronaVac vs. BNT162b2 Vaccination Up to 90 Days Post-Booster
 
 
Article

Article Versions Notes

Antibodies 2022, 11(4), 76; https://doi.org/10.3390/antib11040076
Action Date Notes Link
article xml file uploaded 12 December 2022 12:40 CET Original file -
article xml uploaded. 12 December 2022 12:40 CET Update https://www.mdpi.com/2073-4468/11/4/76/xml
article pdf uploaded. 12 December 2022 12:40 CET Version of Record https://www.mdpi.com/2073-4468/11/4/76/pdf
article html file updated 12 December 2022 12:42 CET Original file -
article html file updated 1 March 2023 03:49 CET Update -
article html file updated 4 March 2023 21:03 CET Update https://www.mdpi.com/2073-4468/11/4/76/html
Back to TopTop